Europe Blood and Blood Components Market by Manufacturers, Regions, Type and Application Forecast to 2024 The Europe Blood and Blood Components Market report research highlights key dynamics of the global sector. The potential of the industry has been investigated along with the key challenges. The current market scenario and prospects of the sector has also been studied. Rising prevalence of incidences such as road accidents, trauma, and surgeries, amongst others across the European continent, have called in for massive demand of blood and blood components, which has in turn propelled the Europe blood and blood components market expansion. Besides, increasing cosmetic surgeries and rising reconstructive surgeries used for reshaping the body structures affected by injuries, birth defects, infections and developmental abnormalities in the region will also impel the demand for blood components in the near future. According to Global Market Insights, Inc. report, Europe blood and blood components market is estimated to register USD 5 billion by 2025. Rising bleeding disorders in the region. Increase in conditions of bleeding disorders, anemia, various procedures such as aesthetic surgeries and chemotherapy along with infections will have a strong influence on the demand of blood components thereby boosting the segmental growth. Moreover, high cost of blood components used for some specific applications will increase the revenue over the coming years. Reportedly, in 2017, the segment had accounted for a revenue share of over 70% in the blood components market. Elevating cancer treatment procedures. Cancer treatment segment is projected to depict a rapid growth on account of increasing prevalence of different types of cancer conditions which increases the requirement for blood components. The blood components are needed for maintaining the count of blood cells. Further, unhealthy eating habits and lifestyle has increased the risk of cancer in the region which will drive the demand for cancer treatment, thus escalating the adoption of blood and blood components. There have been numerous awareness campaigns undertaken by prominent institutions in the region for promoting the donation of blood and blood components essential for cancer treatment. For instance, according to a report by Anthony Nolan and NHS Stem Cell Registry, over 1.4 million registrations were recorded for stem cell donations at the end of 2017. In many cases, stem cells and bone marrow can help with the cancer treatment and increases the chance of survival. Increasing prominence of ambulatory surgical centers © 2022 Global Market Insights Inc. All Rights Reserved
www.gminsights.com